Explore chapters and articles related to this topic
Complications of Absorbable Fillers
Published in Ali Pirayesh, Dario Bertossi, Izolda Heydenrych, Aesthetic Facial Anatomy Essentials for Injections, 2020
Maurizio Cavallini, Gloria Trocchi, Izolda Heydenrych, Koenraad De Boulle, Benoit Hendrickx, Ali Pirayesh
In addition to the presence of previous fillers, the differential diagnosis of periorbital edema (Figure G.2) includes Inflammatory/allergic conditionsRenal diseaseCardiac failureThyroid diseaseHelminthic infectionsAutoimmune disease LEDermatomyositisPrevious fillers
Maxillofacial trauma and ocular injuries: reports from a prospective study from Pondicherry, India
Published in Orbit, 2022
Shravya Choudhary Balla, Kirti Nath Jha, Sathyanarayanan Ramanujam, Krishnagopal Srikanth, Adithyapuram Ramachandran Rajalakshmi
High incidence of periorbital edema is a common clinical finding across all studies.1,9 Periorbital edema was seen in 75.5% of our cases. Mohanavalli et al. reported periorbital edema/ ecchymosis in the majority (79%); periorbital edema was the most common finding in midfacial fractures. We noted nine (8.1%) cases of orbital emphysema – four in relation to zygomaticomaxillary complex fracture, four in relation to nasal bone fracture and one in relation to blow out fracture. Mittal et al. reported orbital emphysema in 2.1% cases of midfacial fractures.1 Subconjunctival haemorrhage is another common finding.1,9 We observed corneal abrasion more frequently (5.9%) than others.1 About 2.2% patients in our study had hyphema which was similar to other studies.1,11
Acute intensive care unit management of mustard gas victims: the Turkish experience*
Published in Cutaneous and Ocular Toxicology, 2018
Ertugrul Kilic, Mesut Ortatatli, Sermet Sezigen, Rusen Koray Eyison, Levent Kenar
Since eyes are more susceptible to SM than any other organ of the body, 12–70 mg/min/m3 of SM causes mild irritation, and 100–200 mg/min/m3 exposure causes moderate irritation. Severe eye lesions can occur if the exposure concentration is higher than 200 mg/min/m3 (9). In our experience, conjunctivitis was observed in all patients at the 18th hour, but 5 cases had mild irritation and 3 cases had moderate irritation with corneal opacity and ulceration. Four cases had temporary loss of vision with periorbital edema and blepharospasm. According to the recommendations, our cases received treatment with mydriatics and appropriate anti-bacterial and steroid eye drops, resulting in complete eye symptom relief by the 15th day. The exceptions were the two cases with corneal opacity, which healed by the 30th day.
Nutritional Status of Patients with Chronic Myeloid Leukemia Treated with Imatinib Mesylate
Published in Nutrition and Cancer, 2022
María José Castillo-Martínez, Elena Juventina Tuna-Aguilar, María del Pilar Milke-García, Anaís Camacho Zamora, Viviana Villegas Cervantes, Lilia Castillo-Martínez
A total of 81 patients were invited to participate in the study from December 2014 to February 2019, three patients were excluded for not meeting the eligibility criteria (one patient had heart failure and two patients decided not to participate); therefore, 78 patients (61.5% men) with chronic myeloid leukemia in chronic (82.1%) or accelerated phase (19.9%) were enrolled. The median CML duration was 80 months (P25th 31–P75th 121). Demographic and clinical characteristics are reported in Table 1. The mean age was 43.5 ± 13.56 years. Clinical edema was detected in more than 33% of the patients, periorbital edema being the most common. The mean BMI was 27.9 ± 6.3 kg/m2 and most of the patients were overweight or obese (n = 55, 70.5%).